NovoCure: 3 Key Takeaways for Long-Term Investors
Published . Updated .
Japan's emergence as a second major market is offsetting headwinds in pancreatic cancer, testing whether geographic diversification can sustain growth.
Directly affected
- NVCR NovoCure
Named in this report.
Indirectly affected
- EWJ iShares MSCI Japan ETF-0.2% 30d
iShares MSCI Japan ETF holds stocks listed in Japan, which this story is about (“japan”).
- EFA iShares MSCI EAFE ETF-2.2% 11d
iShares MSCI EAFE ETF is a broad fund of developed-market stocks that includes Japan, which this story is about.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that NovoCure belongs to, so it often moves with news about it.
- SYK Stryker+6.3% 30d
Stryker is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.
- MMM 3M+2.4% 30d
3M is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.
- BSX Boston Scientific-4.0% 30d
Boston Scientific is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.
- BDX Becton, Dickinson and+6.6% 30d
Becton, Dickinson and is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.
- MDLN Medline-12.3% 12d
Medline is a peer of NovoCure in surgical and medical instruments and apparatus; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| NVCR | +9.63% | +7.65% | base | after close | after close | after close | after close |
| EWJNo price data for this ticker | — | — | — | — | — | — | — |
| EFANo price data for this ticker | — | — | — | — | — | — | — |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| SYKNo price data for this ticker | — | — | — | — | — | — | — |
| MMMNo price data for this ticker | — | — | — | — | — | — | — |
| BSXNo price data for this ticker | — | — | — | — | — | — | — |
| BDXNo price data for this ticker | — | — | — | — | — | — | — |
| MDLNNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
NovoCure: 3 Key Takeaways for Long-Term Investors Yahoo Finance
Source: Yahoo Finance
Spdr Dow Jones Industrial Average Etf Trust (DIA) since “NovoCure: 3 Key Takeaways for Long-Term Investors,” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| NVCR | three days earlier | +7.65% | final price |
| NVCR | five days earlier | +9.63% | final price |
Congressional trades in the stocks in this story
- Sen. John Boozman sold EFA (jointly held), worth $1,001 - $15,000 on 9 Sep 2026. That is 54 days before publication. Filed 21 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 9 Sep 2026. That is 54 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 4 Sep 2026. That is 59 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 60 days before publication. Filed 25 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “NovoCure: 3 Key Takeaways for Long-Term Investors”
Companies tied to this story
- DIA Spdr Dow Jones Industrial Average Etf Trust
Spdr Dow Jones Industrial Average Etf Trust (DIA) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “NovoCure: 3 Key Takeaways for Long-Term Investors.” Reason on file: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story
- QQQ Invesco Qqq Trust, Series 1
For “NovoCure: 3 Key Takeaways for Long-Term Investors,” Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence. Reason on file: Invesco QQQ: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story
- IWM Ishares Tr
In “NovoCure: 3 Key Takeaways for Long-Term Investors,” Ishares Tr (IWM) is linked, with no stored direction, medium confidence. Reason on file: iShares Russell 2000 ETF: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story
- RSP Invesco Exchange Traded Fd T
In “NovoCure: 3 Key Takeaways for Long-Term Investors,” Invesco Exchange Traded Fd T (RSP) is linked, with no stored direction, medium confidence. Reason on file: Invesco S&P 500 Equal Weight ETF: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story
- VTI Vanguard Index Fds
In “NovoCure: 3 Key Takeaways for Long-Term Investors,” Vanguard Index Fds (VTI) is linked, with no stored direction, medium confidence. Reason on file: Vanguard Total Stock Market ETF: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story
How “NovoCure: 3 Key Takeaways for Long-Term Investors” reaches Spdr Dow Jones Industrial Average Etf Trust (DIA)
The 2 Nov 2026 story “NovoCure: 3 Key Takeaways for Long-Term Investors” names Spdr Dow Jones Industrial Average Etf Trust (DIA) because of this story.
Spdr Dow Jones Industrial Average Etf Trust (DIA) is on the page because SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story
Invesco Qqq Trust, Series 1 (QQQ) is here too. Its reason reads: Invesco QQQ: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story
Dates and price levels for Spdr Dow Jones Industrial Average Etf Trust (DIA)
DIA traded between 504.92 and 522.62 across 18 sessions. The latest close on file is 515.65. IWM traded between 269.88 and 285.25 across 20 sessions. The latest close on file is 279.37. QQQ traded between 683.47 and 762.84 across 20 sessions. The latest close on file is 690.51.
A simple score for Spdr Dow Jones Industrial Average Etf Trust (DIA)
40 out of 100
“NovoCure: 3 Key Takeaways for Long-Term Investors” scores 40 out of 100. The score uses 1 sources, and 5 linked companies.